Use of protein C or the activation peptide of protein C for prep

Details Use of protein C or the activation peptide of protein C for prep Use of protein C or the activation peptide of protein C for prep

1995-01-20

1996-11-05

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

A61K 3816

Patent

active

055717861

ABSTRACT:
There is disclosed the use of protein C and/or the activation peptide of protein C for preparing a pharmaceutical preparation having anti-nociceptive activity. This pharmaceutical preparation is useful in the treatment of painful conditions caused by acute or chronic inflammatory processes (such as rheumatoid arthritis, myositis, gastritis, colitis, inflammations in the urogenital tract).

REFERENCES:
patent: 4518608 (1985-05-01), Kahan
patent: 4604285 (1986-08-01), Smith et al.
patent: 4772585 (1988-09-01), Sarnoff et al.
patent: 4849403 (1989-07-01), Stocker et al.
patent: 4902614 (1990-02-01), Wakabayoshi et al.
patent: 4908314 (1990-03-01), Orthner
patent: 4944943 (1990-07-01), Eschenfelde et al.
patent: 5009889 (1991-04-01), Taylor et al.
patent: 5084273 (1992-01-01), Hirahara
patent: 5084274 (1992-01-01), Griffin et al.
patent: 5093117 (1992-03-01), Lawrence et al.
patent: 5151268 (1992-09-01), Bang et al.
English language abstract of PCT Patent No. WO 9008556 (corresponding to U.S. Pat. No. 5,093,117).
English language abstract of European Patent No. EP 326014 (corresponding to U.S. Pat. No. 5,084,273).
P. C. Comp et al., "Evidence for multiple roles for activated protein C in fibrinolysis", Chemical Abstracts vol. 93 No. 3, 1980, p. 424.
P. C. Comp et al., "Generation of fibrinolytic activity by infusion of activated protein C into dogs", Chemical Abstracts vol. 95 No. 25, 1981, p. 347.
G. Kohler et al., "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity", Nature, 256:495-497, (1975).
Randall et al., "A Method For Measurement of Analgesic Activity On Inflamed Tissue", Arch. Int. Pharmacodyn., CXI, 4:409-419, (1957).
Kisiel et al., "Isolation, Characterization, and Mechanism of Activation by .alpha.-Thrombin", (1979) J. Clin. Invest. 64:761-769.
Kisiel et al., "Anticoagulant Properties of Bovine Plasma Protein C Following Activation by Thrombin", (1977) Biochemistry 16(26):5824-5831.
Taylor et al., "Protein C Prevents the Coagulopathic and Lethal Effects of Escherichia coli Infusion in the Baboon", (1987, Mar.) J. Clin. Invest. 79:918-925.
Suzuki et al., "Inactivation of Human Coagulation Factor V by Activated Protein C", (1983) J. Biol. Chem. 258(3):1914-1920.
Esmon et al., "Proteolytic Formation and Properties of .gamma.-Carboxyglutamic Acid-domainless Protein C", (1983) J. Biol. Chem. 258(9):5548-5553.
Esmon et al., "Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C", (1991, Jul. 12) Thrombosis Hemostasis 66(1):160-165.
Johnson et al., "Structural Changes Required for Activation of Protein C Are Induced by Ca.sup.2+ Binding to a High Affinity Site That Does Not Contain .gamma.-Carboxyglutamic Acid", (1983) J. Biol. Chem. 258(9):5554-5560.
The Merck Index (1983) Tenth Ed., p. 123.
Comp et al., "Generation of Fibrinolytic Activity by Infusion of Activated Protein C Into Dogs", (1981) J. Clin. Invest. 68:1221-1228.
Esmon et al, "Protein C and the Endothelium", Seminars in Thrombosis and Hemostasis, vol. 14 (2), 1988, pp. 210-215.
Zurborn et al., Biological Abstracts, vol. 85 (1988), No. 37736.
G. Kohler et al., "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity", Nature, 256:495-497, (1975).
Randall et al., "A Method For Measurement of Analgesic Activity On Inflamed Tissue", Arch. Int. Pharmacodyn., CXI, 4:409-419, (1957).
Jorens et al Blut 1990 61 pp. 307-310.
Roper, "New Amerc. Pocket Medical Dictionary", p. 30 .COPYRGT.1978.

Affiliated with

Also associated with

Rating

Use of protein C or the activation peptide of protein C for prep does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of protein C or the activation peptide of protein C for prep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of protein C or the activation peptide of protein C for prep will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2015213